The Impact of Various Reactive Oxygen Species on the Formation of Neutrophil Extracellular Traps by Kirchner, Tina et al.
Hindawi Publishing Corporation
Mediators of Inﬂammation
Volume 2012, Article ID 849136, 10 pages
doi:10.1155/2012/849136
Research Article
The Impact of Various Reactive Oxygen Specieson the
Formation of Neutrophil Extracellular Traps
Tina Kirchner,1 SonjaM¨ oller,1 Matthias Klinger,2 Werner Solbach,1
Tam´ as Laskay,1 andMartina Behnen1
1Institute for Medical Microbiology and Hygiene, University of L¨ ubeck, Ratzeburger Allee 160, 23538 L¨ ubeck, Germany
2Institute of Anatomy, University of L¨ ubeck, Ratzeburger Allee 160, 23538 L¨ ubeck, Germany
Correspondence should be addressed to Martina Behnen, martina.behnen-haerer@uksh.de
Received 4 November 2011; Revised 21 December 2011; Accepted 22 December 2011
Academic Editor: Johan Bylund
Copyright © 2012 Tina Kirchner et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The formation of neutrophil extracellular traps (NETs) depends on the generation of reactive oxygen species (ROS). Previous
studies revealed that both NADPH oxidase and myeloperoxidase (MPO) are required for NET release. However, the contribution
of various ROS as well as the role of mitochondria-derived ROS has not been addressed so far. In the present study we aimed to
investigateinasystematicandcomprehensivemannerthecontributionofvariousROSandROS-generatingpathwaystothePMA-
induced NET release. By using speciﬁc inhibitors, the role of both NADPH oxidase- and mitochondria-derived ROS as well as the
contribution of superoxide dismutase (SOD) and MPO on the NET release was assessed. We could demonstrate that NADPH
oxidase function is crucial for the formation of NETs. In addition, we could clearly show the involvement of MPO-derived ROS in
NET release. Our results, however, did not provide evidence for the role of SOD- or mitochondria-derived ROS in NET formation.
1.Introduction
In addition to the well-known capacity of neutrophils to
phagocytose and kill invading microorganisms intracellu-
larly[1],neutrophilscancaptureandkillpathogensextracel-
lularly through the release of neutrophil extracellular traps
(NETs) [2]. These complex three-dimensional structures
contain several antimicrobial neutrophil granule proteins
which are attached to a DNA backbone [2]. The novel
cell death mechanism NETosis has been described as the
mechanism leading to the formation of NETs [3, 4]. Studies
with neutrophils from patients with chronic granulomatous
disease (CGD) indicated an essential role of NADPH oxidase
activity in PMA-induced NET release [5]. Although the oxi-
dant dependence of PMA-induced NET formation has been
established, no comprehensive studies have been carried
out so far to assess the role of individual reactive oxygen
species (ROS) and/or the enzymatic pathways involved in
their generation.
Patients completely deﬁcient in myeloperoxidase (MPO)
fail to form neutrophil extracellular traps upon exposure to
PMA [6]. A regulatory role of MPO on the NET release has
also been described [7]. The observation that singlet oxygen
is essential for NET formation [8] further substantiates the
involvement of MPO and MPO-derived hypochlorous acid
(HOCl) in NET formation.
In addition to NADPH oxidase, the mitochondrial elec-
tron transport chain is another source of intracellular ROS.
The contribution of mitochondria-derived ROS regarding
its contribution to NET formation, however, has not been
addressed so far.
In the present study we aimed to investigate in a system-
atic and comprehensive manner the contribution of various
reactive oxygen species and ROS-generating pathways to
the PMA-induced NET release. By using speciﬁc inhibitors,
the impact of both the NADPH- and mitochondria-derived
ROS as well as the contribution of superoxide dismutase
(SOD) and myeloperoxidase (MPO) on the NET release was
assessed. The results conﬁrm previous ﬁndings that NADPH
oxidase function is crucial for the formation of NETs. In
addition, we could clearly show the involvement of oxidative
MPO functions in NET release. However, according to our
results, neither the mitochondria-derived ROS nor SOD play
a major role in NET formation.2 Mediators of Inﬂammation
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Figure 1: Generation and inhibition of ROS in neutrophils. The generation of superoxide (O2
•−) from oxygen (O2) is mediated either by
the NADPH oxidase complex (NOX) or in mitochondria by cytochrome c peroxidase or xanthine oxidase. Superoxide will be converted to
hydrogen peroxide (H2O2) either spontaneously or mediated by superoxide dismutase (SOD). Hydrogen peroxide is a source of hydroxyl
radical (OH•) via the Fenton reaction. Myeloperoxidase uses hydrogen peroxide as substrate for the formation of halogenated ROS such as
hypochlorite (OCl−). Reaction of hypochlorite with hydrogen peroxide will result in the formation of singlet oxygen (1O2). The eﬀect of
the inhibitors used in the study (10µMR o t e n o n e ,1 0µM Dinitrophenol, 500nM FCCP, 20µMD P I ,3 8µMA r o c l o r ,1 0µM DETC, 200µM
Dipyrone and 200µM Aminopyrine) is indicated.
2.MaterialsandMethods
2.1. Isolation and Culture of Primary Human Neutrophils.
Peripheral blood was collected by venipuncture from healthy
adult volunteers using lithium heparin. Neutrophils were
isolatedasdescribedpreviously[9].Thebloodcollectionwas
conducted with the understanding and the consent of each
participantandwasapprovedbytheethicalcommitteeofthe
Medical Faculty of the University of L¨ ubeck (05-124). The
cell preparations contained >99.9% granulocytes as deter-
mined by morphological examination of Giemsa-stained
cytocentrifuged slides (Shandon, Pittsburgh, PA) [10]. Neu-
trophils were cultured using complete medium (RPMI
1640mediumsupplementedwith50µM2-mercaptoethanol,
10mM HEPES, 10% heat inactivated fetal bovine serum
(all from Sigma-Aldrich, Steinheim, Germany), 4mM L-
glutamine,100U/mLpenicillin,100µg/mLstreptomycin(all
from Biochrom, Berlin, Germany)) at 37◦C in a humidiﬁed
air atmosphere containing 5% CO2.
2.2. Inhibitors. To inhibit the NADPH oxidase (NOX) di-
phenyl-eneiodonium chloride (20µM, DPI, Sigma-Aldrich,
Steinheim, Germany) was used. Inhibitors of myeloperox-
idase (MPO) were Dipyrone hydrate (200µM, Dipyrone)
or 4-dimethylaminoantipyrine (200µM, Aminopyrine, both
Sigma-Aldrich). Inhibitors of superoxide dismutase (SOD)
were diethyldithiocarbamic acid (10µM, DETC, Alexis,
L¨ orrach, Germany) or Aroclor 1242 (38µM, Aroclor, Su-
pelco Analytical, Bellefonte, USA). To inhibit ROS produc-
tion by the mitochondria the electron transport inhibitor
Rotenone (10µM ,C a l b i o c h e m ,M e r c k ,D a r m s t a d t ,G e r -
many)andtheuncouplingchainreagents2,4-Dinitrophenol
(10µM, Dinitrophenol, Supelco Analytical) or carbonyl
cyanide p-[triﬂuoromethoxy]-phenyl-hydrozone (500nM
FCCP, Sigma-Aldrich) were used (Figure 1).
For all experiments, freshly isolated human neutrophils
were preincubated for 30min at 37◦C with the inhibitors
listed above. As control, neutrophils were incubated in
medium alone.
2.3. Assessment of Neutrophil Apoptosis and Viability. Freshly
isolated human neutrophils (5 × 106/mL in complete
medium) were incubated with or without inhibitors for 4h
at 37◦C. The solvents DMSO (0.01%, Sigma-Aldrich) and
methanol (1%, Th. Geyer, Renningen, Germany) were used
as control. The samples were analyzed by staining with
Annexin V-FITC (Promokine, Heidelberg, Germany) and
propidium iodide (Sigma-Aldrich). Annexin V exhibits
calcium-dependent binding to phosphatidylserine (PS) ex-
pressed in the outer membrane leaﬂet of apoptotic PMN
[11]. Labeling of apoptotic cells with Annexin V-FITC and
counterstaining with propidium iodide (PI) for necrotic cells
were performed as recommended by the manufacturers. The
labeled cells were analyzed immediately by ﬂow cytometry
using a FACS Calibur ﬂow cytometer and the CellQuest Pro
software (BD Biosciences, San Diego, USA).
2.4. Assays for ROS Production. Three assays were used to
measure production of intracellular, extracellular, or intra-
cellular and extracellular reactive oxygen species by human
neutrophils, respectively.
2.4.1. Intracellular Oxidative Burst Assay Using Flow Cytome-
try. The intracellular production of ROS was assayed by ﬂow
cytometry using the substrate dihydrorhodamine 123 (DHR
123, Invitrogen, Eugene, USA) that diﬀuses into the cells and
is oxidized by ROS to the ﬂuorescent Rhodamine 123. With
this method, it is possible to evaluate the response of indi-
vidual cells. Freshly isolated human neutrophils (5×106/mL
in complete medium) were preincubated with the previously
described inhibitors for 30min at 37◦C. Subsequently, 2µM
DHR 123 were added, and cells were stimulated with 4µM
phorbolmyristateacetate(PMA,Sigma-Aldrich)for5minatMediators of Inﬂammation 3
37◦C. The reaction was stopped on ice, and the ﬂuorescence
intensity of the cells was analyzed immediately by ﬂow cy-
tometry using a FACS Calibur ﬂow cytometer and the
CellQuest Pro software.
2.4.2.Luminol-AmpliﬁedChemiluminescenceAssay. Thesum
of intra- and extracellular ROS was measured by using a
luminol-ampliﬁed chemiluminescence assay. Due to the fact
that MPO-derived metabolites are responsible for the excita-
tion of luminol (5-amino-2,3-dihydro-1,4-phthalazindione)
[12] and because neutrophils release MPO from azurophil
granules (degranulation) during their activation, not only
intracellular but also extracellular ROS can be detected by
this technique.
4 ×105 freshly isolated human neutrophils (2 ×106/mL)
in CL medium (a custom-made RPMI-modiﬁed medium
without phenol red and sodium hydrogen carbonate con-
taining 20mM HEPES (Biochrom, Berlin, Germany)) were
seeded in a ﬂat bottom white 96-well plate (Nunclon Delta
Surface, Nunc, Langenselbold, Germany) and preincubated
with speciﬁc inhibitors for 30min at 37◦C. Subsequently
0.06mM luminol (Sigma-Aldrich) was added, and cells were
stimulated with 20nM PMA (Sigma-Aldrich). Neutrophils
without PMA treatment were used as control. The chemi-
luminescence resulting from ROS production was analyzed
immediately using an inﬁnite 200 reader and the Tecan
i-control 1.7 Software (Tecan, Crailsheim, Germany). ROS
release was monitored every 2 minutes for a period of 1h at
37◦C.
2.4.3. Lucigenin-Ampliﬁed Chemiluminescence Assay. The
lucigenin-enhanced chemiluminescence assay was used to
study the kinetic of superoxide production by neutrophils.
Lucigenin speciﬁcally emits light upon reaction with super-
oxide, but is not being excited by MPO-derived ROS [12,
13]. Furthermore lucigenin detects only extracellular but
not intracellular ROS because it cannot penetrate the cell
membrane [14]. For the lucigenin assay neutrophils were
treated as described above in the luminol assay, but with
0.2mM lucigenin (Alexis, Loerrach, Germany) instead of
luminol.
2.5. Induction and Detection of Neutrophil Extracellular Traps.
Staining with the non-cell-permeable DNA dye SYTOXgreen
(Invitrogen)wasusedtostudythekineticsofNETformation
by neutrophils incubated with or without speciﬁc inhibitors.
Per sample 2 × 105 neutrophils in NET medium (CL
medium supplemented with 0.5% human serum albumin
(Behring, Marburg, Germany) and 10mM HEPES buﬀer
(PAA, Pasching, Austria)) were seeded to a cellstar 96-
well plate (Greiner Bio-One, Frickenhausen, Germany) and
preincubated with the speciﬁc inhibitors for 30min at 37◦C.
To detect the extracellular DNA of neutrophil extracellular
traps, 5µM SYTOXgreen was added, and the neutrophils
were stimulated with 20nM PMA. The ﬂuorescence of NET-
bound SYTOXgreen (excitation: 488nm, emission: 510nm)
was analyzed for a period of 4h every 5min at 37◦C using
an inﬁnite 200 reader and Tecan i-control 1.7 Software
(Tecan).
2.6. Microscopical Assessment of NET Formation. To visu-
alize NETs, ﬂuorescence microscopy and scanning elec-
tron microscopy (SEM) were performed. For these tech-
niques freshly isolated human neutrophils were centrifuged
for 10min, 1045×g, and resuspended in NET medium
(1 × 106/mL). 5 × 105 neutrophils with inhibitors or in
medium alone were settled on poly-L-lysine-coated cover-
slips (BD BioCoat Cellware, Bedford, USA) for ﬂuorescence
microscopy or on thermanox slides (Thermanox coverslips,
Nunc) for SEM. After incubation for 30min at 37◦C NET
formation was induced with 20nM PMA for 4h. Samples
without PMA were used as control. At this point the further
treatment for ﬂuorescence and SEM samples diﬀers. For
ﬂuorescence microscopy the samples were ﬁxed with 4%
paraformaldehyde (Sigma-Aldrich) for 10min at room tem-
perature. Subsequently, the supernatant was removed, and
the air-dried coverslips were rehydrated in PBS and stained
with 100nM SYTOXgreen for 30min in the dark at room
temperature. After washing three times with nuclease free
water (Sigma-Aldrich), the samples were mounted with Pro-
Long Gold antifade reagent (Invitrogen) and analyzed under
an Axioskop 40 ﬂuorescence microscope using the Axio
Vision Rel. 4.8-Software (both Carl Zeiss, Jena, Germany).
For staining of neutrophil elastase, after rehydration with
PBS, samples were blocked overnight with 10% normal goat
serum (Jackson Immuno Research, Newmarket, UK), 5%
cold water ﬁsh gelatine (Sigma-Aldrich), 1% bovine serum
albumin (Roth, Karlsruhe, Germany), and 0.05% Tween 20
(Serva, Heidelberg, Germany) diluted in PBS. Afterwards the
samples were washed with PBS and incubated with anti-
neutrophil elastase rabbit pAb (1:200; Calbiochem, Merck,
Darmstadt, Germany) for 1h at 37◦C. After washing three
times with PBS, the primary antibody was detected with
Cy3-AﬃniPure anti-Rabbit IgG (1:100; Jackson Immuno
Research, Newmarket, UK) for 1h and DNA was stained
with 100nM SYTOXgreen. Samples for scanning electron
microscopy were ﬁxed in a Monti-Graziadei solution (2%
glutaraldehyde, 0.6% paraformaldehyde in 0.1M cacodylate
buﬀer, at pH 7.2) for 2 days and then dehydrated in a rising
alcohol series (30, 40, 50, 60, 70, 80, 90, and 100% for 15min
each). After critical-point drying, the samples were placed
on aluminium slides and subsequently sputtered with gold.
Samples were examined in a SEM 505 (Philips, Eindhoven,
Holland).
2.7. Statistical Analysis. Statistical analysis was performed
with graph pad prism 4 software. Data were analyzed using
the one way Anova test and Bonferroni posttest.
3. Results and Discussion
3.1. The Applied Inhibitors of ROS Production Are Not
Toxic and Do Not Induce Apoptosis in Neutrophils. For
the inhibitors acting on various steps of intracellular ROS
production (Figure 1)e ﬀective concentrations were chosen
either based on previous reports [5, 15–19]o rb yo u ro w n
preliminary studies (data not shown). To exclude a toxic
eﬀect of the inhibitors, all inhibitors were tested for their
toxicity (necrosis) and apoptosis-inducing eﬀect on primary4 Mediators of Inﬂammation
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Figure 2: Inhibitors of various steps of ROS production are not toxic and do not induce apoptosis in human neutrophils. Freshly isolated
human neutrophils were incubated with or without inhibitors (10µMR o t e n o n e ,1 0µM Dinitrophenol, 500nM FCCP, 20µMD P I ,3 8µM
Aroclor, 10µM DETC, 200µM Dipyrone, and 200µM Aminopyrine) for 4h at 37◦C. DMSO and methanol were used as solvent controls
for Rotenone and Aroclor. Apoptosis and cell death were assessed by ﬂow cytometry using stainings with Annexin V-FITC and propidium
iodide, respectively. (a) The eﬀect of various inhibitors on apoptosis and necrosis of neutrophils in vitro. Data are shown as mean from 3
independent experiments. (b) Representative dot plot of a ﬂow cytometry analysis of human neutrophils cultured without inhibitor. The x-
axisshowstheAnnexinV-FITCﬂuorescence,atthe y-axisthepropidiumiodideﬂuorescenceisindicated.Eventsinthelowerrightquadrante
(1.08%) represent the apoptotic cells whereas events in the upper quadrants represent the necrotic population.
human neutrophils. By using ﬂow cytometry analysis of a
doublestainingwithAnnexinV-FITCandpropidiumiodide,
none of the applied inhibitors exerted a toxic or apoptosis-
inducing eﬀect after 4h (Figure 2). Necrosis or apoptosis
induction was also not seen after longer (18h) incubation
(data not shown).
3.2. The Eﬀect of Various Inhibitors on the Intra- and/or
Extracellular ROS Production by Neutrophils. Prior to testing
their eﬀects on NET release, all inhibitors were tested for
their eﬃcacy to inhibit PMA-induced ROS production.
Three widely used ROS detection methods were tested for
their applicability for our project. As a ﬁrst approach, the
intracellular ROS production in neutrophils loaded with
DHR 123 was measured by using ﬂow cytometry. H2O2
rather than O2
•− is required to oxidise the nonﬂuorescent
DHR 123 to the ﬂuorescent Rhodamin 123 derivate [20].
This slow reaction is catalysed by enzymes with peroxidase
activity such as MPO. Although the DHR oxidation is
promoted by H2O2, this assay can also be used to detect
O2
•−, because the dismutation of O2
•− to H2O2 and oxygen
is rapid even in the absence of SOD [20]. DPI, an inhibitor of
NOX and complex I of the mitochondrial electron transport
chain, exerted a strong inhibitory eﬀect on intracellular ROS
production measured in this assay (Figure 3). The SOD
inhibitors Aroclor and DETC had no inhibitory eﬀect. The
MPO inhibitors, Dipyrone and Aminopyrine, also decreased
the ﬂuorescence intensity (Figure 3(a)).
Although the DHR 123-based technique is simple and
rapid, this method is not very sensitive [21]. This could
possibly be the reason why high PMA concentrations were
needed to detect a burst and no clear results were obtained
forthemitochondrial inhibitors(Figure 3(a)).Insubsequent
experiments more sensitive test methods were applied.
The lucigenin-ampliﬁed chemiluminescence assay is a
sensitive technique to quantify extracellular ROS, mainly
superoxide anions (O2
•−)[ 12, 13]. By using this technique
a strong inhibitory eﬀect was observed for DPI (Figure 4),
which completely abolishes superoxide production. In addi-
tion, the uncoupling mitochondrial chain reagents FCCP
and Dinitrophenol exerted signiﬁcant inhibitory eﬀects
(Figure 4(b)). The other inhibitors did not exert a marked
eﬀect by using the lucigenin-ampliﬁed chemiluminescence
assay (Figure 4).
As a third technique the luminol-ampliﬁed chemilumi-
nescence assay was applied to assess the eﬀects of various
inhibitors on ROS production. This technique detects both
intra- and extracellular ROS. In contrast to lucigenin,
which is mainly oxidized by O2
•−, luminol can be oxidized
b ys e v e r a lR O S ,s u c ha sH 2O2, HOCl, and HO• [22,
23]. Experiments using this technique revealed that DPI
nearly completely abolished ROS production (Figure 5). The
MPO-inhibitors Dipyrone and Aminopyrine prevented theMediators of Inﬂammation 5
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Figure 3: Flow cytometry analysis of intracellular ROS production by neutrophils after exposure to various inhibitors. Freshly isolated
human neutrophils were incubated with or without inhibitors (10µMR o t e n o n e ,1 0µM Dinitrophenol, 500nM FCCP, 20µMD P I ,3 8µM
Aroclor, 10µM DETC, 200µM Dipyrone, and 200µM Aminopyrine) for 30min at 37◦C. Cells were loaded with DHR 123, and the
samples were stimulated with 4µM PMA. The intracellular production of ROS was assessed by using ﬂow cytometry. (a) Geometrical mean
(GeoMean) values of the ﬂuorescence intensities normalized to the PMA-induced ROS production in the absence of inhibitors (Medium).
Data show mean ± SD from four independent experiments, ∗: P<0.001 as compared to the PMA-stimulated sample without inhibitor
(Medium). (b) Representative histogram showing the ﬂuorescent intensities of unstimulated neutrophils (without PMA), PMA-stimulated
neutrophils without inhibitor (Medium), and, as an example for an inhibitory eﬀect, PMA-stimulated neutrophils after exposure to DPI.
Data are from one experiment representative for three independent experiments.
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Figure 4: Extracellular ROS production of neutrophils incubated with various inhibitors as measured by the lucigenin-ampliﬁed
chemiluminescence assay. Freshly isolated human neutrophils were incubated with or without inhibitors (10µMR o t e n o n e ,1 0 µM
Dinitrophenol, 500nM FCCP, 20µMD P I ,3 8µMA r o c l o r ,1 0µM DETC, 200µM Dipyrone, and 200µM Aminopyrine) for 30min at 37◦C.
Subsequently, lucigenin was added, and the ROS production was induced with 20nM PMA. The O2
•−-release was detected by measuring
chemiluminescence for a period of 1h at 37◦C. The control without PMA shows the O2
•−-release of unstimulated neutrophils. (a) Time
kinetics of O2
•−-release (chemiluminescence) in one representative experiment. (b) O2
•−-release quantiﬁed by calculation of the area under
the curve (AUC). Data show mean ± SD from four independent experiments, ∗∗: P<0.001; ∗: P<0.01 as compared to the PMA-stimulated
sample without inhibitor (Medium).6 Mediators of Inﬂammation
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Figure 5: Assessment of intra- and extracellular ROS production of neutrophils after exposure to various inhibitors as measured by
the luminol-ampliﬁed chemiluminescence assay. Freshly isolated human neutrophils were incubated with or without inhibitors (10µM
Rotenone, 10µM Dinitrophenol, 500nM FCCP, 20µMD P I ,3 8µMA r o c l o r ,1 0µM DETC, 200µM Dipyrone, and 200µM Aminopyrine) for
30min at 37◦C. Subsequently, luminol was added, and the ROS production was induced with 20nM PMA. The H2O2 release was detected
by measuring chemiluminescence for a period of 1h at 37◦C. (a) Time kinetics of H2O2 release (chemiluminescence) of one representative
experiment. (b) H2O2 release quantiﬁed by calculation of the area under the curve (AUC). Data show mean ± SD from three independent
experiments, ∗∗: P<0.001; ∗: P<0.01 as compared to the PMA-stimulated sample without inhibitor (Medium).
MPO-induced oxidation of luminol with high eﬃciency
(Figure 5), but had no inhibitory eﬀect in the lucigenin assay
(Figure 4), indicating that Aminopyrine und Dipyrone have
no inhibitory eﬀect on NOX. The mitochondrial uncou-
pling reagents FCCP and Dinitrophenol exerted signiﬁcant
inhibitory eﬀects as well (Figure 5(b)). Rotenone, however,
didnotinhibitPMA-inducedROSproduction.Fromthetwo
testedSODinhibitorsAroclorexertedasigniﬁcantinhibitory
eﬀect. The eﬀect of DETC was statistically not signiﬁcant
(Figure 5(b)).
3.3. The Eﬀect of Various Inhibitors of ROS Production on
NET Release by Primary Human Neutrophils. Major sources
of ROS in neutrophils are the enzymatic reactions mediated
by NADPH oxidase and MPO [19, 24]. In addition, ROS
are produced in mitochondria through the function of the
mitochondrial electron transport chain. Since PMA-induced
NETreleasewasshowntodependonROS[2]itwastoexpect
that inhibition of pathways involved in ROS generation
leads to reduction of NET formation. The above-described
assays conﬁrmed the inhibitory eﬀect of DPI, Dipyrone,
Aminopyrine, FCCP, Dinitrophenol, and Aroclor on the
ROS production and in part on ROS release by human
neutrophils.
The eﬀect of these inhibitors on the PMA-induced NET
release by neutrophils was assessed. In these experiments
only those substances were tested that showed an inhibitory
eﬀect on ROS production in any of the above-described
ROS production tests. The panel of inhibitors contained
substances targeting the NOX-mediated and/or mitochon-
drial ROS production, as well as SOD- or MPO-derived
ROS (Figure 1). Human neutrophils were preincubated for
30min with the inhibitors prior to NET induction with
PMA. The NET release was quantiﬁed by measuring the
ﬂuorescence of SYTOXgreen over a period of 4h. Inhibition
of NADPH oxidase with the inhibitor DPI abolished NET
release (Figure 6). DPI, however, in addition to NADPH
oxidase inhibits also the mitochondrial electron transport
chain [25]. Therefore, the observed NET-inhibiting eﬀect
of DPI can be a result of its known inhibitory eﬀect on
NADPH oxidase or on mitochondrial ROS production or
both. In order to dissect the two possible targets of DPI,
experiments were carried out with inhibitors targeting the
mitochondrial ROS release. The studies using mitochon-
drial inhibitors aimed also to decipher the contribution of
mitochondrial ROS production on the NET formation. To
inhibit mitochondrial ROS production, we used FCCP and
Dinitrophenol, two substances that uncouple the mitochon-
drial oxidative phosphorylation. Uncoupler agents dissipate
the mitochondrial membrane potential which is generated
for the production of ATP by transporting protons across
the membrane. Consequently, the electron transport chain
functions more eﬃciently to reestablish the proton gradient
that results into less leakage of electrons, and therefore less
ROS are generated [26–28]. Both FCCP and Dinitrophenol
were shown previously to inhibit the production of ROS
in PMA-stimulated neutrophils [29, 30]. In addition, the
FCCP-mediated reduction in ROS release is due to theMediators of Inﬂammation 7
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Figure 6: Release of NETs by neutrophils after exposure to various ROS inhibitors as measured by the SYTOXgreen assay. Freshly isolated
human neutrophils were incubated with or without inhibitors (10µM Dinitrophenol, 500nM FCCP, 20µMD P I ,3 8µM Aroclor, 200µM
Dipyrone, and 200µM Aminopyrine) for 30min at 37◦C. Subsequently, 5µMS Y T O X g r e e nw a sa d d e dt oa l ls a m p l e s ,a n df o r m a t i o no f
NETs was induced by 20nM PMA. Samples without PMA were used as control. The NET production was detected for a period of 4h
at 37◦C by measuring the ﬂuorescence of DNA-bound SYTOXgreen. (a) Time kinetics of NET release (ﬂuorescence intensity) of one
representative experiment. (b) Quantiﬁcation of NET release by calculation of the area under the curve (AUC). Data show mean ± SD
from three independent experiments, ∗: P<0.01 as compared to the PMA-stimulated sample without inhibitor (Medium).
mitochondrial uncoupling [29]. An unspeciﬁc inhibition of
oxidative burst could be excluded at concentrations below
1µM[ 29]. Although the mitochondrial inhibitors FCCP
and Dinitrophenol signiﬁcantly reduced ROS generation in
neutrophils (Figures 4(b) and 5(b)), no inhibitory eﬀect
on NET release was observed (Figure 6). These ﬁndings
indicate that mitochondrial ROS do not play a major role
in the PMA-induced NET release. Our experiments with
the mitochondrial inhibitors also indicate that the inhibitory
eﬀect of DPI on NET release is associated with the eﬀect of
DPI on NADPH oxidase.
As described previously, MPO is required for PMA-
induced NET release [6]. To further elucidate the role
of MPO-derived ROS, experiments with Aminopyrine and
Dipyrone were carried out to assess the contribution of
MPO to the NET release. It has been shown previously that
these inhibitors prevent PMA-induced ROS production in
human neutrophils [19]. This eﬀect is due to the scavenging
of hypochlorite and hydroxyl radicals by Aminopyrine
and Dipyrone [19] and to the inhibition of MPO by
Aminopyrine [31]. Our data show that Aminopyrine and
Dipyrone prevent the MPO-induced oxidation of DHR
123 and luminol (Figures 3 and 5) but failed to inhibit
the superoxide-dependent oxidation of lucigenin (Figure 4).
In line with previous ﬁndings [19], these results indicate
that Aminopyrine and Dipyrone have no scavenging eﬀect
against superoxide and no inhibitory eﬀect on NOX. Both
Dipyrone and Aminopyrine inhibited signiﬁcantly NET
release (Figure 6(b)). These results provide experimental
evidence that MPO enzymatic activity and MPO-derived
ROS are required for NET release. Hypochlorite (OCl−)i s
the likely MPO-derived ROS involved in the process of NET
formation. The interaction of hypochlorite with hydrogen
peroxide (H2O2) leads to the generation of singlet oxygen.
Singlet oxygen has been reported to be essential for NET
formation [8].
As inhibitor of SOD we used Aroclor, a mixture of
polychlorinated biphenyls. In a previous study it was shown
that preincubation of human neutrophils with Aroclor
impaired the PMA-induced ROS release by inhibiting SOD,
which converts O2
•− to H2O2 and oxygen [17]. In line with
this ﬁnding we observed a signiﬁcant downregulation of
H2O2 by using the luminol assay (Figure 5). Exposure of
neutrophils to the SOD inhibitor Aroclor did not signiﬁ-
cantly aﬀect PMA-induced NET release (Figure 6). Appar-
ently this ﬁnding contradicts the observations regarding the
involvement of MPO-derived ROS and singlet oxygen [8]
in NET release. However, in a previous study SOD was
also not required for PMA-induced hypochlorite (OCl−)
production [32]. SOD appears to be not essential for the
productionofhydrogenperoxide(H2O2).Indeedsuperoxide
can be dismutated to hydrogen peroxide spontaneously,
without the need for enzymatic dismutase activity [33]. This
spontaneous dismutase reaction increases with decreasing
pH value and can convert signiﬁcant levels of superoxide to
hydrogenperoxideatneutralpHwitharateof2×105 M−1s−1
[33]. Interestingly, although hydrogen peroxide release was
signiﬁcantly downregulated by Aroclor (Figure 5), Aroclor
had no signiﬁcant eﬀect on the NET release. Neutrophils
from some of the donors, however, exhibited an increased8 Mediators of Inﬂammation
Figure 7: Release of NETs by neutrophils after exposure to various ROS inhibitors assessed by ﬂuorescent and scanning electron microscopy
(SEM). Freshly isolated human neutrophils were preincubated with various ROS inhibitors (20µMD P I ,3 8 µM Aroclor, and 200µM
Dipyrone) for 30min at 37◦C. NET release was induced by 20nM PMA, and the samples were ﬁxed after 4h. NET release was detected by
ﬂuorescent microscopy and SEM. (a-b) DNA staining with SYTOXgreen and neutrophil elastase or (c–g) with SYTOXgreen alone. (a) and
(c) unstimulated neutrophils, (b) and (d) PMA-stimulated neutrophils in medium (without inhibitor), (e–g) PMA-stimulated neutrophils
exposed to a ROS inhibitor.
NET formation (Figure 6(a)). This could be due to the fact
that inhibition of SOD leads to an imbalance between pro-
duction of free radicals and antioxidant defense mechanism.
It has been shown previously that in parallel to a decrease
in H2O2 production, O2
•− production increases by use of
Aroclor [17]. We observed a minor, but statistically not sig-
niﬁcant Aroclor-induced increase in superoxide production
by using the DHR 123 assay (Figure 3). This eﬀect could be
responsible for the slightly enhanced NET release observed
in some of the experiments.
Fluorescent microscopy and scanning electron microsco-
py (SEM) were used to verify the eﬀects observed by using
the quantitative NET release technique. NET formation was
visualized at 4h after PMA stimulation. As examples for the
eﬀect of various inhibitors, Figures 7(e) and 7(g) conﬁrm
the absence of NETs in the presence of DPI and Dipyrone,
respectively. The microscopical analysis also conﬁrmed that
the SOD-inhibitor Aroclor does not inhibit PMA-induced
NET release (Figure 7(f)).
The release of NETs is an important antimicrobial effect-
ormechanismofneutrophils.However,NETscanbeharmful
if they are released in the absence of microbial infections,
such as in autoinﬂammatory or autoimmune disorders. A
dysregulation of NETs has been shown, for example, in
small-vesselvasculitis[34]andsystemiclupuserythematosus
[35]. Increased knowledge of the mechanisms involved in
NET release would lead to better understanding regarding
the pathophysiology of autoinﬂammatory and autoimmune
diseases and may lead to the development of novel thera-
peutic strategies. Our study indicates that NOX- and MPO-
derived ROS, but not mitochondrial ROS are important for
the release of NETs. In addition, we could show that ROS
scavengers such as Aminopyrine and Dipyrone eﬀectively
inhibit NET release. Therefore, ROS scavengers could be
potential therapeutic agents for the suppression of NET
release.
4. Conclusions
The presented data indicate the importance of NADPH
oxidase- and myeloperoxidase-(MPO-) derived ROS for the
PMA-induced formation of neutrophil extracellular traps
(NETs). Mitochondria-derived ROS as well as the contri-
bution of superoxide dismutase (SOD) are, however, not
essential for the release of NETs.
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